Magnesium Sulfate Injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia, respectively.
When used judiciously, it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant.
Magnesium Sulfate Injection is currently on the ASHP drug shortage list of essential medications.
This approval and near-term launch of Magnesium Sulfate Injection will help to reduce supply issues experienced in the US.
This achievement marks the second ANDA approval this year for Milla Pharmaceuticals Inc. and the Alter Pharma Group and clears the path for the group to the third launch of an Alter Pharma product in the US market.
Milla Pharmaceuticals Inc. is engaged in the development, licensing, acquisition, and commercialization of generic prescription drugs for the US market focused on niche injectable and solution products for hospitals and clinics.
Woodward Pharma Services is a specialty pharmaceutical company focused on acquiring, licensing, and commercializing brand and generic prescription drugs for the US Market.
The company has a diverse portfolio of products distributed across multiple channels.
Apotex launches Teriparatide Injection in US
Teva Pharmaceuticals secures FDA approval for generic Forteo (teriparatide injection)
Upsher-Smith Laboratories introduces Pitavastatin Tablets
Par Pharmaceutical starts shipping colchicine 0.6mg capsules
Padagis launces Brinzolamide Ophthalmic Suspension with CGT exclusivity
Novartis completes Sandoz Spin-off
Novartis completes Sandoz spin-off, focusing on innovative medicines
Sanofi and Teva collaborate on innovative IBD treatment
Hikma marks KLOXXADO two-year anniversary by surpassing 375,000 doses donated in the US
STADA seeks full approval for Kinpeygo in IgA nephropathy from UK MHRA
Azurity Pharmaceuticals completes Slayback Pharma acquisition
Sandoz secures European approval for Tyruko biosimilar in MS treatment
Senores Pharmaceuticals introduces Nicardipine Hydrochloride Capsules USP, 20mg and 30mg in US
Lupin collaborates with Mark Cuban Cost Plus Drug Company and COPD foundation
Certara Simcyp receives FDA grants for advanced pharmacokinetic modelling